{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:02:22Z","timestamp":1789498942632,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prro.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:03:26Z","timestamp":1789495406000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten-year outcomes of PET-directed salvage nodal radiotherapy and temporary ADT for N1 and M1a hormone-sensitive prostate cancer"],"prefix":"10.1016","author":[{"given":"Cristian J.","family":"Salazar V","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Wilhite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Stish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Waddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan R.","family":"Jethwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Orme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance A.","family":"Mynderse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene D.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8288-1096","authenticated-orcid":false,"given":"Brian J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prro.2026.09.003_bib0001","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2017.07.011","article-title":"Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease","volume":"8","author":"Evans","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.prro.2026.09.003_bib0002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.prro.2026.09.003_bib0003","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.prro.2026.09.003_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(02)02411-1","article-title":"Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy","volume":"61","author":"Kane","year":"2003","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.prro.2026.09.003_bib0006","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijrobp.2016.11.014","article-title":"Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography\/Computed Tomography","volume":"97","author":"Parker","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.prro.2026.09.003_bib0007","first-page":"1270","article-title":"(11)C-Choline PET\/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients","volume":"41","author":"Picchio","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.prro.2026.09.003_bib0008","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S1470-2045(19)30486-3","article-title":"Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial","volume":"20","author":"Carrie","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10338","key":"10.1016\/j.prro.2026.09.003_bib0009","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.prro.2026.09.003_bib0010","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.euo.2023.09.007","article-title":"PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial","volume":"7","author":"Ost","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.prro.2026.09.003_bib0011","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","article-title":"NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer","volume":"109","author":"Hall","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.prro.2026.09.003_bib0012","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2967\/jnumed.117.201749","article-title":"(68)Ga-PSMA-11 PET\/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng\/mL: Impact on Salvage Radiotherapy Planning","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med."},{"issue":"5","key":"10.1016\/j.prro.2026.09.003_bib0013","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.eururo.2018.10.044","article-title":"Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates","volume":"75","author":"De Bruycker","year":"2019","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prro.2026.09.003_bib0014","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.05.029","article-title":"Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology\/American Urological Association guidelines","volume":"86","author":"Valicenti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0015","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"10.1016\/j.prro.2026.09.003_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/JU.0000000000001376","article-title":"Advanced Prostate Cancer: AUA\/ASTRO\/SUO Guideline PART II","volume":"205","author":"Lowrance","year":"2021","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0017","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.prro.2026.09.003_bib0018","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00259-023-06445-4","article-title":"Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET\/CT: ten-year results in patients enrolled in a prospective trial","volume":"51","author":"Fodor","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.prro.2026.09.003_bib0019","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2011.02.024","article-title":"Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis","volume":"59","author":"Briganti","year":"2011","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.prro.2026.09.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv119","article-title":"Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer","volume":"107","author":"Lin","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.prro.2026.09.003_bib0021","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2014.01.008","article-title":"The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study","volume":"88","author":"Rusthoven","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0022","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2021.06.010","article-title":"OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer","volume":"80","author":"Supiot","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0023","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijrobp.2022.05.040","article-title":"Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer","volume":"114","author":"Rich","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.prro.2026.09.003_bib0024","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ijrobp.2022.04.048","article-title":"Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy","volume":"113","author":"Zamboglou","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.prro.2026.09.003_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(25)00658-8","article-title":"Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration","volume":"27","author":"Tang","year":"2026","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.prro.2026.09.003_bib0026","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa1212299","article-title":"Intermittent versus continuous androgen deprivation in prostate cancer","volume":"368","author":"Hussain","year":"2013","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2025.01.010","article-title":"Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer","volume":"87","author":"Azad","year":"2025","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.prro.2026.09.003_bib0028","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.prro.2026.09.003_bib0029","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1470-2045(24)00730-7","article-title":"ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial","volume":"26","author":"Marvaso","year":"2025","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.prro.2026.09.003_bib0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JU.0000000000000800","volume":"204","author":"Fossati","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0031","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijrobp.2023.10.009","article-title":"Pelvic Irradiation for Node-Positive Prostate Cancer After Prostatectomy: Long-Term Results of the Prospective PLATIN-4 and PLATIN-5 Trials","volume":"118","author":"Fink","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.prro.2026.09.003_bib0032","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.adro.2019.06.006","article-title":"(11)C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities","volume":"4","author":"Jethwa","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.prro.2026.09.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.06.1106","article-title":"A Randomized, Parallel Phase II Trial of Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer with Pelvic and\/or Para-aortic Lymph Node Involvement Following Primary Localized Treatment with Radiotherapy","volume":"123","author":"Davis","year":"2025","journal-title":"International Journal of Radiation Oncology*Biology*Physics"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:03:30Z","timestamp":1789495410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026002833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S1879850026002833"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.09.003","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year outcomes of PET-directed salvage nodal radiotherapy and temporary ADT for N1 and M1a hormone-sensitive prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}